- Home
- ELAB vs SNOA Comparison
ELAB vs SNOA Comparison
Compare ELAB & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- SNOA
- Stock Information
- Founded
- ELAB 2020
- SNOA 1999
- Country
- ELAB United States
- SNOA United States
- Employees
- ELAB N/A
- SNOA N/A
- Industry
- ELAB
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- ELAB
- SNOA Health Care
- Exchange
- ELAB Nasdaq
- SNOA Nasdaq
- Market Cap
- ELAB 6.6M
- SNOA 6.4M
- IPO Year
- ELAB 2023
- SNOA 2007
- Fundamental
- Price
- ELAB $2.16
- SNOA $2.90
- Analyst Decision
- ELAB
- SNOA
- Analyst Count
- ELAB 0
- SNOA 0
- Target Price
- ELAB N/A
- SNOA N/A
- AVG Volume (30 Days)
- ELAB 1.5M
- SNOA 33.3K
- Earning Date
- ELAB 08-13-2025
- SNOA 06-17-2025
- Dividend Yield
- ELAB N/A
- SNOA N/A
- EPS Growth
- ELAB N/A
- SNOA N/A
- EPS
- ELAB N/A
- SNOA N/A
- Revenue
- ELAB N/A
- SNOA $14,288,000.00
- Revenue This Year
- ELAB N/A
- SNOA $38.54
- Revenue Next Year
- ELAB N/A
- SNOA N/A
- P/E Ratio
- ELAB N/A
- SNOA N/A
- Revenue Growth
- ELAB N/A
- SNOA 12.20
- 52 Week Low
- ELAB $1.95
- SNOA $1.75
- 52 Week High
- ELAB $840.00
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- ELAB 45.40
- SNOA 38.85
- Support Level
- ELAB $1.96
- SNOA $2.81
- Resistance Level
- ELAB $2.26
- SNOA $3.45
- Average True Range (ATR)
- ELAB 0.22
- SNOA 0.13
- MACD
- ELAB 0.03
- SNOA -0.05
- Stochastic Oscillator
- ELAB 17.95
- SNOA 10.77
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.